Next-gen gut health delivery using bacterial vesicles for precise, effective, and cost-efficient supplement delivery.
BioClé has raised $200K in total funding. The most recent round was Seed. The last funding was announced in May 2026.
BioClé's investors include Big Idea Ventures, GRID EXPONENTIAL.
BioClé is headquartered in Rosario, Argentina.
Next-gen gut health delivery using bacterial vesicles for precise, effective, and cost-efficient supplement delivery.
BioClé is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioClé — Funding & Investors." VCBacked, May 18, 2026, https://www.vcbacked.co/company/biocl. Accessed October 31, 2026.
VCBacked. (2026). BioClé — Funding & Investors. Retrieved October 31, 2026, from https://www.vcbacked.co/company/biocl
{{cite web |title=BioClé — Funding & Investors |url=https://www.vcbacked.co/company/biocl |website=VCBacked |access-date=October 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated